|
End-of-day quote
LUXEMBOURG S.E.
18/09/2026
|
5-day change | 1st Jan Change | ||
| 40.20 USD | -1.47% |
|
+0.50% | +33.11% |
| 18/09 | EU Medicines Agency Panel Issues Positive Opinion on Gedeon Richter's Arthritis Drug | MT |
| 12/08 | Gedeon Richter PLC, Q2 2026 Earnings Call, Aug 07, 2026 |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Data source:
Gedeon Richter(RICHTER)
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Data source:
Gedeon Richter(RICHTER)
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
Data source:
Gedeon Richter(RICHTER)
EBIT
Dividend / Share (DPS)
Data source:
Gedeon Richter(RICHTER)
Cash or Net Debt
- Stock Market
- Stocks
- RICHTER Stock
- CHWGR Stock
- Consensus Gedeon Richter
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
